What
A prescription blood test that can help diagnose cancers based on detection of organ specific Circulating Tumor Cells (CTCs).
For Whom
• Patients who have been advised a biopsy to
rule out suspected cancer.
• Patients in whom a recent biopsy has been inconclusive.
• Patients in whom a biopsy is not feasible.
• Patients who are suspected of cancer recurrence.
How
Circulating tumor cells are isolated from a patient’s blood sample and extensively analyzed to assist in the diagnosis of cancer.
Why
Invasive biopsies are expensive, risk-prone procedures. Many patients who undergo a biopsy are diagnosed with benign conditions. Trublood™, which requires only a simple blood draw, can reduce the need for biopsies in patients with benign conditions.
Revolutionary Technology
The cutting-edge technology that powers Trublood™ is validated stringently to meet global standards.
Advantages
- Non-invasive, safe, convenient, and patient-friendly.
- No need for hospitalization/visit to an advanced healthcare facility.
- No risks of pain, bleeding, or infection.
- Suitable at preliminary presentation as well as for suspected recurrence.
- Suitable for radiologically undetectable tumors.
Explore
Explore
- Screening
- Therapy Guidance
- Monitoring
A Simple Blood Test To Detect Cancer Early,
So That It Could Be Cured.
Accreditations*
